pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 2
    NG-350A
    Epithelial Tumor Akamis Bio Ltd
  • Phase 1
    NKT-3964
    Adenocarcinoma Of The Gastroesophageal Junction NiKang Therapeutics Inc
  • Phase 1
    NM-6603
    Colorectal Cancer Nucmito
  • Phase 1
← prev
page 28 of 62
next →
Pain89
Neurology1
NMS-812
Refractory Acute Myeloid Leukemia
Nerviano Medical Sciences SRL
  • Phase 1
    NN-3201
    Adenoid Cystic Carcinoma (ACC) Novelty Nobility Inc
  • Preclinical
    NOD-2
    Unspecified Cancer Nodus Oncology Ltd
  • Phase 2
    NOUS-209
    Gastric Cancer Nouscom AG
  • Preclinical
    NOVS-100
    Obesity Celloram Inc
  • Preclinical
    NP-855
    Neuroblastoma NanoPharmaceuticals LLC
  • Phase 3
    NPG-2044
    Ovarian Cancer Novita Pharmaceuticals Inc
  • Phase 1
    NPX-887
    Adenocarcinoma Of The Gastroesophageal Junction NextPoint Therapeutics Inc
  • Phase 2
    NT-219
    Metastatic Colorectal Cancer$PPBT PURPLE BIOTECH LTD.
  • Phase 3
    NTO-1151
    Triapine
    Cervical Cancer Resilience Government Services Inc
  • Phase 2
    NTX-301
    Chronic Myelomonocytic Leukemia (CMML) Pinotbio Inc
  • Preclinical
    NU-001
    Ovarian Cancer NUAgo Therapeutics Inc
  • phase_0
    NU-0129
    Gliosarcoma Northwestern University
  • Preclinical
    NV-101
    Ewing Sarcoma Oncology Pharma Inc
  • Phase 2
    NVX-108
    perflenapent
    Glioblastoma Multiforme (GBM) NuvOx Pharma LLC
  • Phase 1
    NX-1607
    Adenocarcinoma Of The Gastroesophageal Junction$NRIX Nurix Therapeutics, Inc.
  • Phase 1
    NXP-900
    Cervical Cancer$NVCT Nuvectis Pharma, Inc.
  • Preclinical
    Nanoapalutamide
    Prostate Cancer Nanoform Finland Plc
  • Preclinical
    Nanoparticle Mesothelin MOTO-CAR
    Solid Tumor Thunder Biotech Inc
  • Phase 2
    Nerofe
    Nerofe
    Refractory Acute Myeloid Leukemia Immune System Key Ltd
  • Preclinical
    Next-generation CAR-T
    Ovarian Cancer ToolGen Inc
  • Preclinical
    No Alpha IL-2 Mutein
    Unspecified Cancer Roswell Park Cancer Institute
  • Preclinical
    Novel Molecules for Glioma
    Glioma$MRK Merck & Co., Inc.
  • Preclinical
    Novel Therapeutic
    Glioblastoma Multiforme (GBM) Rosalind Franklin University of Medicine and Science
  • Phase 2
    OBI-902
    Bile Duct Cancer (Cholangiocarcinoma) OBI Pharma Inc
  • Phase 2
    OBX-115
    Metastatic Melanoma Obsidian Therapeutics Inc
  • Preclinical
    OCX-410
    Non-Small Cell Lung Carcinoma$OCEA Ocean Biomedical, Inc.